Regarding the latter, the decree indicates: “In establishments that are not authorized as pharmacies, the marketing of over-the-counter medications will be limited to antacids and analgesics.”
Through a post on his X account, the Minister of Deregulation and State Transformation, Federico Sturzenegger, explained: “Previously, any business was subject to a large number of requirements (monetary guarantees, maximum temperatures, etc.) for sale of over-the-counter medications that are eliminated by this decree. Now a kiosk or supermarket will be able to sell this type of medicine with no other restriction than the prohibition of sales to minors.”
image.png
Along these lines, the minister highlighted three foundations for this deregulation. #First, for convenience, since they can be added to the weekly purchase in your store or supermarket,” he said. And he continued: “Second, because in many places, a pharmacy is far away and then being able to purchase them in other places facilitates access to these medications. “If I have a child with a fever, I don’t want the regulation to impose the obligation to travel dozens of kilometers to go to a pharmacy to buy ibuprofen.”
And thirdly, he pointed out: “It will allow greater price competition. We have already said that in antacids like omeprazole there are price differences that are 8 times. With a more agile commercial channel and more focused on price, I really doubt that these differences can be maintained for a long time.
- Legal documentation: You must prove the right to the property according to current legislation. Have an insurance policy that covers risks associated with the sale of pharmaceutical products, with a minimum insured sum equivalent to 750 minimum, vital and mobile salaries.
- Storage conditions: Medications must be able to be stored in a space independent of other products, under lock and key, with the conditions of hygiene, safety, spaciousness, light and ventilation determined by the Enforcement Authority. Keep medications out of direct access to the public and out of the reach of children; They must be delivered exclusively by establishment personnel.
- Fractionation is not allowed: It is prohibited to sell to minors under 18 years of age and to divide the primary or secondary packaging of the products.
Read also: The Government changed the bridge holidays for “non-working days”: what is the difference and how many will there be in 2025
**Beyond price competition, what other innovative strategies could be implemented to ensure that increased access to OTC medications translates into improved health outcomes for the Argentine population?**
## Wider Access to Medicines: A Discussion with Experts
**Introduction:**
Welcome to World Today News. Today, we’re discussing the recent deregulation of over-the-counter (OTC) medication sales in Argentina, allowing supermarkets and kiosks to sell certain medicines alongside their usual stock. Joining us to dissect the implications of this change are:
* **Dr. Maria Sanchez**, a public health expert with extensive experience in pharmacy access and regulations.
* **Mr. Juan Perez**, a representative from a leading supermarket chain, offering insight into the practical implementation of these changes.
**Section 1: Convenience and Accessibility**
**Host:** Minister Sturzenegger emphasizes the convenience factor of this change, highlighting the ease of adding OTC medicines to regular shopping trips. Dr. Sanchez, do you think this convenience outweighs potential concerns about the appropriateness of selling medication in non-traditional settings?
**Dr. Sanchez:**
**(Discussion point: Weighing the convenience of access against potential concerns about providing medical advice in non-pharmacy settings.)**
**Host:** Mr. Perez, how do you anticipate this change impacting your customer base and operational procedures within your supermarket?
**Mr. Perez:**
**(Discussion point: Practical implementation from a supermarket perspective, including staff training, storage considerations, and potential challenges.)**
**Section 2: Regulation and Safety**
**Host:** The new decree stipulates specific regulations for the sale of OTC medications in non-pharmacy settings, including age restrictions and secure storage requirements. Dr. Sanchez, how confident are you that these regulations are robust enough to ensure the safe distribution and use of these medicines?
**Dr. Sanchez:**
**(Discussion point: Evaluating the adequacy of the new regulations, considering potential loopholes and the need for ongoing monitoring.)**
**Host:** Mr. Perez, from a business standpoint, how feasible and cost-effective will it be to comply with these new regulations, especially concerning storage and staff training?
**Mr. Perez:**
**(Discussion point: Business perspective on the implementation costs and logicial feasibility of adhering to the new regulatory framework.)**
**Section 3: Price Competition and Affordability**
**Host:** Minister Sturzenegger argues that increased competition may lead to lower prices for OTC medications. Mr. Perez, do you anticipate a significant impact on pricing strategies within your supermarket chain due to this deregulation?
**Mr. Perez:**
**(Discussion point: Impact on price competition and potential benefits for consumers in terms of affordability.)**
**Host:** Dr. Sanchez, while price competition is positive, is there a risk that prioritizing affordability might overshadow important factors like product quality and pharmaceutical expertise?
**Dr. Sanchez:**
**(Discussion point: Balancing affordability with the need for quality control and access to qualified pharmaceutical advice.)**
**Conclusion:**
Thank you to Dr. Sanchez and Mr. Perez for sharing their valuable insights. This deregulation marks a significant shift in the accessibility of OTC medications, presenting both opportunities and challenges.
It remains crucial to monitor its long-term impact on public health, market dynamics, and consumer well-being, ensuring convient access to medications while maintaining safety and responsible pharmaceutical practices.
